These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38741449)

  • 1. Prophylactic range anti-factor Xa activity 24 hours after subcutaneous injection of 40 mg of enoxaparin in a patient with an epidural catheter in situ.
    Czempik PF
    Anaesthesiol Intensive Ther; 2024; 56(1):86-88. PubMed ID: 38741449
    [No Abstract]   [Full Text] [Related]  

  • 2. Establishment of prophylactic enoxaparin dosing recommendations to achieve targeted anti-factor Xa concentrations in children with CHD.
    Israel EN; Thomas CA; Mastropietro CW
    Cardiol Young; 2018 May; 28(5):715-718. PubMed ID: 29490713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic anticoagulation with enoxaparin: Is the subcutaneous route appropriate in the critically ill?
    Priglinger U; Delle Karth G; Geppert A; Joukhadar C; Graf S; Berger R; Hülsmann M; Spitzauer S; Pabinger I; Heinz G
    Crit Care Med; 2003 May; 31(5):1405-9. PubMed ID: 12771610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed-dose enoxaparin after bariatric surgery: the influence of body weight on peak anti-Xa levels.
    Celik F; Huitema AD; Hooijberg JH; van de Laar AW; Brandjes DP; Gerdes VE
    Obes Surg; 2015 Apr; 25(4):628-34. PubMed ID: 25223871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight-based enoxaparin with anti-factor Xa assay-based dose adjustment for venous thromboembolic event prophylaxis in adult trauma patients results in improved prophylactic range targeting.
    Rodier SG; Bukur M; Moore S; Frangos SG; Tandon M; DiMaggio CJ; Ayoung-Chee P; Marshall GT
    Eur J Trauma Emerg Surg; 2021 Feb; 47(1):145-151. PubMed ID: 31471669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Anti-Factor Xa-Guided Dosing of Enoxaparin With Venous Thromboembolism After Trauma.
    Karcutskie CA; Dharmaraja A; Patel J; Eidelson SA; Padiadpu AB; Martin AG; Lama G; Lineen EB; Namias N; Schulman CI; Proctor KG
    JAMA Surg; 2018 Feb; 153(2):144-149. PubMed ID: 29071333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual Enoxaparin Activity, Anti-Xa Levels, and Concerns About the American Society of Regional Anesthesia and Pain Medicine Anticoagulation Guidelines.
    Henshaw DS; Turner JD; Forest DJ; Thompson GR; Weller RS
    Reg Anesth Pain Med; 2017; 42(4):432-436. PubMed ID: 28492441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pharmacodynamics of enoxaparin in percutaneous coronary intervention with precise rapid enoxaparin loading (PEPCI-PRE study).
    Martin JL; Fry ET; Martin T; Atherley TH; Martin SS; Slepian MJ
    J Thromb Thrombolysis; 2009 Aug; 28(2):224-8. PubMed ID: 19291367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supraprophylactic Anti-Factor Xa Levels Are Associated with Major Bleeding in Neurosurgery Patients Receiving Prophylactic Enoxaparin.
    May CC; Cua S; Smetana KS; Powers CJ
    World Neurosurg; 2022 Jan; 157():e357-e363. PubMed ID: 34655821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of enoxaparin 40 mg versus 60 mg dosage for venous thromboprophylaxis in patients undergoing bariatric surgery: A randomized controlled trial.
    Kongsawat K; Chaivanijchaya K; Pakul F; Joradol S; Kachornvitaya P; Boonchaya-Anant P; Udomsawaengsup S
    Asian J Surg; 2024 Jul; 47(7):2985-2990. PubMed ID: 38514281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Weight- and Anti-Xa-Guided Enoxaparin Dosing Protocol for venous thromboembolism Prophylaxis in intensive care unit Trauma Patients.
    Bigos R; Solomon E; Dorfman JD; Ha M
    J Surg Res; 2021 Sep; 265():122-130. PubMed ID: 33930618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Factor Xa Activity of Prophylactic Enoxaparin Regimens in Critically Ill Patients.
    Helviz Y; Dzigivker I; Raveh-Brawer D; Hersch M; Zevin S; Einav S
    Isr Med Assoc J; 2016 Feb; 18(2):108-13. PubMed ID: 26979004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised assessment of the pharmacokinetic, pharmacodynamic and safety interaction between apixaban and enoxaparin in healthy subjects.
    Barrett YC; Wang J; Song Y; Pursley J; Wastall P; Wright R; Lacreta F; Frost C
    Thromb Haemost; 2012 May; 107(5):916-24. PubMed ID: 22398784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weight-Based Dosing for Once-Daily Enoxaparin Cannot Provide Adequate Anticoagulation for Venous Thromboembolism Prophylaxis.
    Pannucci CJ; Hunt MM; Fleming KI; Prazak AM
    Plast Reconstr Surg; 2017 Oct; 140(4):815-822. PubMed ID: 28953735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial.
    Anderson JA; Hirsh J; Yusuf S; Johnston M; Afzal R; Mehta SR; Fox KA; Budaj A; Eikelboom JW
    J Thromb Haemost; 2010 Feb; 8(2):243-9. PubMed ID: 19943881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic Enoxaparin Dosing Using Anti-Factor Xa Levels in Hepatic Surgery Patients: A Pilot Study.
    Coster S; Shammout A; Chaney M; Folkert K; Grosh K; Shebrain S; Munene G
    Am Surg; 2024 Jun; 90(6):1760-1762. PubMed ID: 38490954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twice-Daily Enoxaparin among Plastic Surgery Inpatients: An Examination of Pharmacodynamics, 90-Day Venous Thromboembolism, and 90-Day Bleeding.
    Pannucci CJ; Fleming KI; Momeni A; Prazak AM; Agarwal J; Rockwell WB
    Plast Reconstr Surg; 2018 Jun; 141(6):1580-1590. PubMed ID: 29608533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Enoxaparin Dosage Adjusted by Anti-Factor Xa Trough Level and Clinically Evident Venous Thromboembolism After Trauma.
    Ko A; Harada MY; Barmparas G; Chung K; Mason R; Yim DA; Dhillon N; Margulies DR; Gewertz BL; Ley EJ
    JAMA Surg; 2016 Nov; 151(11):1006-1013. PubMed ID: 27383732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing enoxaparin anti-Xa activity in surgical critically ill patients.
    Vincent PD; Albert M; Champagne MC; Zikos T; Boulanger I; Blais L; Williamson DR
    J Crit Care; 2011 Aug; 26(4):347-51. PubMed ID: 21454037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enoxaparin dosing after cesarean delivery in morbidly obese women.
    Overcash RT; Somers AT; LaCoursiere DY
    Obstet Gynecol; 2015 Jun; 125(6):1371-1376. PubMed ID: 26000508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.